Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Randomized Controlled Trial"
format_facet:"Aufsätze"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Randomized+Controlled+Trial%22&filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&lookfor=%22Chen%2C+Jianhua%22&type=Person
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Randomized+Controlled+Trial%22&filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&lookfor=%22Chen%2C+Jianhua%22&type=Person
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Randomized+Controlled+Trial%22&filter%5B%5D=format_facet%3A%22Aufs%C3%A4tze%22&lookfor=%22Chen%2C+Jianhua%22&type=Person
PubPharm (18)
1
First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302) : a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial
enthalten in:
The Lancet. Respiratory medicine
| 2024
von
Zhong, H.
|
Sun, S.
|
Chen, J.
| +41
Wird geladen...
2
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions
enthalten in:
The New England journal of medicine
| 2023
von
Zhou, C.
|
Tang, K.
|
Cho, B.
| +126
CommentIn: Cancer Discov. 2023 Dec 12;13(12):OF9. - PMID 37878779
Wird geladen...
3
Interim survival analysis of the randomized phase III GEMSTONE-302 trial : sugemalimab or placebo plus chemotherapy as first-line treatment for metastatic NSCLC
enthalten in:
Nature cancer
| 2023
von
Zhou, C.
|
Wang, Z.
|
Sun, M.
| +31
ErratumIn: Nat Cancer. 2024 Jan 5;:. - PMID 38182915
Wird geladen...
4
Camrelizumab Plus Carboplatin and Pemetrexed as First-Line Treatment for Advanced Nonsquamous NSCLC : Extended Follow-Up of CameL Phase 3 Trial
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2023
von
Zhou, C.
|
Chen, G.
|
Huang, Y.
| +54
Wird geladen...
5
Validation of different personalized risk models of chemotherapy-induced nausea and vomiting : results of a randomized, double-blind, phase III trial of fosaprepitant for cancer patients treated with high-dose cisplatin
enthalten in:
Cancer communications (London, England)
| 2023
von
Zhao, Y.
|
Zhao, B.
|
Chen, G.
| +15
Wird geladen...
6
AENEAS : A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon-Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2022
von
Lu, S.
|
Dong, X.
|
Jian, H.
| +56
CommentIn: J Clin Oncol. 2022 Sep 20;40(27):3103-3105. - PMID 35679530
Wird geladen...
7
Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302) : A Randomized Phase III Study
enthalten in:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
| 2022
von
Shen, L.
|
Kato, K.
|
Kim, S.
| +28
ErratumIn: J Clin Oncol. 2023 Dec 19;:JCO2302629. - PMID 38113437
Wird geladen...
8
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq) : A Phase 3 Trial
enthalten in:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
| 2022
von
Ren, S.
|
Chen, J.
|
Xu, X.
| +31
CommentIn: J Thorac Oncol. 2022 Apr;17(4):477-480. - PMID 35307102
Wird geladen...
9
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302) : interim and final analyses of a double-blind, randomised, phase 3 clinical trial
enthalten in:
The Lancet. Oncology
| 2022
von
Zhou, C.
|
Wang, Z.
|
Sun, Y.
| +17
CommentIn: Lancet Oncol. 2022 Feb;23(2):186-188. - PMID 35038431
Wird geladen...
10
Intrapleural infusion of tumor cell-derived microparticles packaging methotrexate or saline combined with pemetrexed-cisplatin chemotherapy for the treatment of malignant pleural effusion in advanced non-squamous non-small cell lung cancer : A double-blind, randomized, placebo-controlled study
enthalten in:
Frontiers in immunology
| 2022
von
Dong, X.
|
Huang, Y.
|
Yi, T.
| +14
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Randomized Controlled Trial
Filter aufheben
Medienart: Aufsätze
Medienart
Aufsätze
18
E-Artikel
18
E-Ressourcen
Zeitschriftentitel
3
Journal of thoracic oncology : official publica...
3
The Lancet. Oncology
3
The Lancet. Respiratory medicine
2
International journal of chronic obstructive pu...
2
Journal of clinical oncology : official journal...
1
Cancer communications (London, England)
1
Clinical cardiology
1
Frontiers in immunology
1
Nature cancer
1
The New England journal of medicine
Alle anzeigen ...
weniger ...
Thema
18
Journal Article
Randomized Controlled Trial
14
Research Support, Non-U.S. Gov't
12
Clinical Trial, Phase III
7
Multicenter Study
6
Antibodies, Monoclonal, Humanized
5
73096E137E
5
BG3F62OND5
5
Carboplatin
5
EC 2.7.10.1
5
camrelizumab
4
04Q9AIZ7NO
4
Pemetrexed
3
Antineoplastic Agents
3
ErbB Receptors
3
Protein Kinase Inhibitors
2
15H5577CQD
2
Antineoplastic Agents, Immunological
2
Camrelizumab
2
Chemotherapy
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
15
2020-
3
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
18
Englisch
Haven't found what you're looking for?
Wird geladen...